Biotech News

The GigaCT: Advancing Photon-Counting CT for Next-Generation Spectral Imaging - Varex Imaging

Varex Imaging (VREX)Varex Imaging2026-07-08 16:03 ESTPartnership

May 18, 2026

Varex Imaging, in collaboration with the Technical University of Munich (TUM) and Schleifring GmbH, has introduced the GigaCT, a next-generation photon-counting CT (PCCT) research system designed to overcome current limitations in spectral imaging. The prototype features a high-speed data architecture and advanced detector technology, enabling improved spatial resolution and material differentiation compared to conventional CT […]

Varex Imaging, in collaboration with the Technical University of Munich (TUM) and Schleifring GmbH, has introduced the GigaCT, a next-generation photon-counting CT (PCCT) research system designed to overcome current limitations in spectral imaging. The prototype features a high-speed data architecture and advanced detector technology, enabling improved spatial resolution and material differentiation compared to conventional CT systems. Early results demonstrate strong potential for applications in clinical research areas such as cardiovascular imaging, oncology, and musculoskeletal studies. As development continues, GigaCT is expected to support new advances in spectral CT imaging, including multi-contrast detection and lower-dose scanning.

Read the full white paper here:

Giga CT White Paper (2)

06

Articles

Open original release

Related news

Varex Imaging

Varex Imaging is a biopharmaceutical company focused on advancing a pipeline of therapeutic programs. Investors usually track how clinical data, regulatory milestones, and launch execution change the story over time.

Recent company news

Stock data

Close
10.80 USD
Market cap
465.72M USD
Exchange
NASDAQ
Sector
Biotechnology
Location
United States